Showing results (1301-1310 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|June 12, 2024
Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved IndicationsCarlos Torrado, Ruth Plummer, Timothy A Yap
JCO Precision Oncology|May 16, 2024
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II TrialJoyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, et al.
JCO Precision Oncology|May 15, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric CancerKyoko Yamaguchi, Mamoru Ito, Taichi Isobe, et al.
JCO Precision Oncology|May 15, 2024
Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future ApproachesRay Manneh, Carmen Alaez Verson, Angel Martin, et al.
JCO Precision Oncology|May 6, 2024
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid CancerAntonio Matrone, Alessandro Prete, Carla Gambale, et al.
JCO Precision Oncology|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING TrialJulieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
JCO Precision Oncology|May 23, 2024
Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction AdenocarcinomaRebecca Waters, Matheus Sewastjanow-Silva, Kohei Yamashita, et al.
JCO Precision Oncology|April 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker AnalysesPanagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, et al.
JCO Precision Oncology|April 25, 2024
Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical TrialsJennyfer M García-Cárdenas, Alberto Indacochea, David Pesantez-Coronel, et al.
Pageof 140